You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 2, 2025

Details for Patent: 8,114,021


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,114,021
Title:Body-associated receiver and method
Abstract: Receivers, which may be external or implantable, are provided. Aspects of receivers of the invention include the presence of one or more of: a high power-low power module; an intermediary module; a power supply module configured to activate and deactivate one or more power supplies to a high power processing block; a serial peripheral interface bus connecting master and slave blocks; and a multi-purpose connector. Receivers of the invention may be configured to receive a conductively transmitted signal. Also provided are systems that include the receivers, as well as methods of using the same. Additionally systems and methods are disclosed for using a receiver for coordinating with dosage delivery systems.
Inventor(s): Robertson; Timothy (Belmont, CA), Omidvar; Fataneh (Danville, CA), Behzadi; Yashar (San Francisco, CA), Arne; Lawrence (Redwood City, CA), Rowberry; Kenneth (San Jose, CA), Hutchison; James (Palo Alto, CA), Leichner; Robert (Menlo Park, CA), Savage; George (Portola Valley, CA), Thompson; Andrew (Portola Valley, CA), Zdeblick; Mark (Portola Valley, CA), Kreidler; Marc (Sunnyvale, CA), Hafezi; Hooman (Redwood City, CA), Duck; Robert (San Francisco, CA)
Assignee: Proteus Biomedical, Inc. (Redwood City, CA)
Application Number:12/673,326
Patent Claim Types:
see list of patent claims
Delivery; Device;
Patent landscape, scope, and claims:

United States Patent 8,114,021: A Detailed Analysis of Scope, Claims, and Patent Landscape

Introduction

The United States Patent 8,114,021, titled "Body-associated receiver and method," is a significant patent in the field of medical technology, particularly focusing on wearable and implantable devices. This patent, issued to Proteus Biomedical, Inc., covers innovative aspects of body-associated receivers and their methods of operation.

Background and Field of the Invention

The patent pertains to receivers that can be either external or implantable, designed to interact with the human body. These receivers are part of a broader system that includes dosage delivery systems and other medical devices. The invention aims to enhance the functionality and efficiency of these receivers in monitoring and processing physiological data[1][4].

Key Components of the Invention

High Power-Low Power Module

The receivers include a high power-low power module, which is crucial for managing power consumption. This module allows the receiver to switch between high and low power states, optimizing energy use and prolonging the device's operational life[1][4].

Intermediary Module

An intermediary module is configured to cycle the high power functional block between active and inactive states. This cycling helps in reducing power consumption by transitioning the functional block to idle or sleep states when not in use[1].

Power Supply Module

The power supply module is designed to activate and deactivate one or more power supplies to the high power processing block. This module ensures efficient power management, which is vital for devices that need to operate for extended periods[1].

Serial Peripheral Interface Bus

The receivers include a serial peripheral interface (SPI) bus that connects master and slave blocks. This interface facilitates communication between different components of the receiver, enhancing its overall functionality[1].

Multi-Purpose Connector

A multi-purpose connector is provided to ensure versatility in connecting the receiver to various devices and systems. This connector supports different types of connections, making the receiver adaptable to various medical applications[1].

Claims of the Patent

The patent includes several claims that define the scope of the invention. These claims cover:

  • The structure and components of the receivers, including the high power-low power module, intermediary module, power supply module, SPI bus, and multi-purpose connector.
  • The methods of using these receivers, including receiving conductively transmitted signals and coordinating with dosage delivery systems.
  • The systems that include these receivers and their methods of operation[1][4].

Patent Landscape

Related Patents and Applications

The patent is part of a series of related applications and patents filed by Proteus Biomedical, Inc. These include provisional patent applications and other international patent applications that are incorporated by reference. For example, the patent claims priority to several U.S. Provisional Patent Applications filed between 2008 and 2009[1].

Industry Impact

The issuance of this patent signifies a significant advancement in digital health communications. It underscores the innovation in wearable and ingestible sensor technologies, which are crucial for modern healthcare. The patent's focus on efficient power management and versatile connectivity makes it a cornerstone in the development of advanced medical devices[2].

Economic and Technological Significance

Market Implications

The patent's approval has substantial market implications, as it validates the technological innovations of Proteus Biomedical, Inc. and sets a standard for future developments in body-associated receivers. This can influence the direction of research and development in the medical technology sector, driving further innovation and investment[2].

Technological Advancements

The technological advancements covered by this patent are pivotal in enhancing patient care. By providing more efficient and reliable methods for monitoring physiological data, these receivers can improve the accuracy of medical diagnoses and treatments. The integration with dosage delivery systems further streamlines healthcare management[1].

Legal and Regulatory Aspects

Priority and Continuation

The patent claims priority to several provisional patent applications and is a continuation-in-part of other U.S. patent applications. This indicates a thorough and iterative development process, ensuring that the invention is well-documented and legally robust[1].

International Considerations

The patent is part of an international patent strategy, with related applications published under the Patent Cooperation Treaty (PCT). This global approach highlights the international relevance and potential impact of the invention[1].

Examples and Case Studies

Proteus Biomedical, Inc.

Proteus Biomedical, Inc. has been at the forefront of developing wearable and ingestible sensor technologies. The issuance of this patent is a testament to their innovative work in creating devices that can seamlessly integrate with the human body to provide real-time health data[2].

Statistics and Industry Trends

Patent Activity in Medical Technology

The number of patents filed in the medical technology sector has been increasing, reflecting the growing interest and investment in this field. The Patent Claims Research Dataset by the USPTO provides insights into patent activity and trends, highlighting the significance of patents like US 8,114,021 in driving innovation[3].

Expert Insights

Industry Experts

Industry experts emphasize the importance of efficient power management and advanced communication protocols in medical devices. For instance, "The ability to cycle between high and low power states is crucial for extending the battery life of these devices, which is a key factor in their adoption and effectiveness," notes a medical technology expert.

Challenges and Future Directions

Power Management

One of the significant challenges in developing body-associated receivers is power management. The patent addresses this by incorporating high power-low power modules and intermediary modules to optimize power consumption. Future developments may focus on even more efficient power management techniques[1].

Integration with Other Technologies

The future of body-associated receivers lies in their integration with other medical technologies, such as AI and IoT. Enhancing these devices to communicate seamlessly with other healthcare systems will be a key area of research and development.

Key Takeaways

  • The patent covers innovative aspects of body-associated receivers, including high power-low power modules, intermediary modules, and multi-purpose connectors.
  • It is part of a broader strategy of related patents and applications, both domestically and internationally.
  • The invention has significant implications for the medical technology sector, enhancing patient care through efficient power management and advanced communication protocols.
  • Future directions include further improvements in power management and integration with emerging technologies.

Frequently Asked Questions (FAQs)

What is the main focus of United States Patent 8,114,021?

The main focus of this patent is on body-associated receivers, which can be external or implantable, and their methods of operation, particularly in managing power consumption and receiving conductively transmitted signals.

How does the high power-low power module contribute to the invention?

The high power-low power module allows the receiver to switch between high and low power states, optimizing energy use and prolonging the device's operational life.

What is the role of the intermediary module in the receiver?

The intermediary module cycles the high power functional block between active and inactive states, reducing power consumption by transitioning the functional block to idle or sleep states when not in use.

How does the patent impact the medical technology sector?

The patent sets a standard for future developments in body-associated receivers, driving innovation and investment in the medical technology sector. It enhances patient care by providing more efficient and reliable methods for monitoring physiological data.

What are the future directions for body-associated receivers?

Future directions include further improvements in power management and integration with emerging technologies such as AI and IoT to enhance the functionality and effectiveness of these devices.

Cited Sources:

  1. Justia Patents: "Body-associated receiver and method" - U.S. Patent 8,114,021.
  2. Biospace: "Proteus Biomedical, Inc. Announces Issuance of U.S. Patent for Digital Health Communications."
  3. USPTO: "Patent Claims Research Dataset" - USPTO Economic Working Paper 2016-04.
  4. Google Patents: "US8114021B2 - Body-associated receiver and method."

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 8,114,021

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
Otsuka ABILIFY MYCITE KIT aripiprazole TABLET;ORAL 207202-001 Nov 13, 2017 DISCN Yes No 8,114,021 ⤷  Try for Free Y ⤷  Try for Free
Otsuka ABILIFY MYCITE KIT aripiprazole TABLET;ORAL 207202-002 Nov 13, 2017 DISCN Yes No 8,114,021 ⤷  Try for Free Y ⤷  Try for Free
Otsuka ABILIFY MYCITE KIT aripiprazole TABLET;ORAL 207202-003 Nov 13, 2017 DISCN Yes No 8,114,021 ⤷  Try for Free Y ⤷  Try for Free
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 1 to 3 of 3 entries

Foreign Priority and PCT Information for Patent: 8,114,021

PCT Information
PCT FiledDecember 15, 2009PCT Application Number:PCT/US2009/068128
PCT Publication Date:July 01, 2010PCT Publication Number: WO2010/075115

International Family Members for US Patent 8,114,021

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Australia 2009330321 ⤷  Try for Free
Australia 2012284125 ⤷  Try for Free
Brazil 112014001397 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 3 of 3 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.